Vaccine-derived poliomyelitis 12 years after infection in Minnesota

Aaron S DeVries, Jane Harper, Andrew Murray, Catherine A Lexau, Lynn Bahta, Jaime Christensen, Elizabeth Cebelinski, Susan Fuller, Susan Kline, Gregory S. Wallace, Jing H. Shaw, Cara C. Burns, Ruth Lynfield

Research output: Contribution to journalArticlepeer-review

72 Scopus citations

Abstract

A 44-year-old woman with long-standing common variable immunodeficiency who was receiving intravenous immune globulin suddenly had paralysis of all four limbs and the respiratory muscles, resulting in death. Type 2 vaccine-derived poliovirus was isolated from stool. The viral capsid protein VP1 region had diverged from the vaccine strain at 12.3% of nucleotide positions, and the two attenuating substitutions had reverted to the wild-type sequence. Infection probably occurred 11.9 years earlier (95% confidence interval [CI], 10.9 to 13.2), when her child received the oral poliovirus vaccine. No secondary cases were identified among close contacts or 2038 screened health care workers. Patients with common variable immunodeficiency can be chronically infected with poliovirus, and poliomyelitis can develop despite treatment with intravenous immune globulin.

Original languageEnglish (US)
Pages (from-to)2316-2323
Number of pages8
JournalNew England Journal of Medicine
Volume364
Issue number24
DOIs
StatePublished - Jun 16 2011

Fingerprint

Dive into the research topics of 'Vaccine-derived poliomyelitis 12 years after infection in Minnesota'. Together they form a unique fingerprint.

Cite this